Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00740857 · ClinicalTrials.gov registry record · Phase 4
Study Comparing the Efficacy of Two Ibuprofen Formulations
A Phase 4 study, sponsored by Wyeth is now a wholly owned subsidiary of Pfizer.
- Completed
- Registry status
- Phase 4
- Development phase
- 211
- Enrollment target
NCT00740857: Completed Phase 4 study, sponsored by Wyeth is now a wholly owned subsidiary of Pfizer.
NCT00740857 is a Phase 4 study that has completed, run by Wyeth is now a wholly owned subsidiary of Pfizer. The registered enrollment target is 211 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (59% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00740857, a Phase 4 study, has completed, sponsored by Wyeth is now a wholly owned subsidiary of Pfizer.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 211 participants
- Enrollment target
Study Summary
This is a study of healthy volunteers to compare how quickly different ibuprofen products relieve dental pain.
Primary Outcome
Subjects evaluated the time to "First Perceptible" Relief by depressing a stopwatch at the moment they first began to experience "perceptible" relief and the time to "Meaningful" Relief by depressing a second stopwatch at the moment they first began to experience "meaningful" relief. These times were recorded up to 6 hrs after dosing. Range: up to 6 hrs, a lower number is better.
Interventions
- DRUG placebo
- DRUG ibuprofen Formulation 1
- DRUG ibuprofen Formulation 2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 211 participants |
| Start Date | 2008-08 |
| Est. Completion | 2008-11 |
| Phase | Phase 4 |
What the finished NCT00740857 record still lists
NCT00740857 is an interventional study that assigns participants to a tested intervention. The registered 211 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (59% lower).
The record links to 0 conditions, and to 3 interventions - of which placebo is the first listed.
NCT00740857 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00740857 about?
NCT00740857 is a clinical study titled "Study Comparing the Efficacy of Two Ibuprofen Formulations". This is a study of healthy volunteers to compare how quickly different ibuprofen products relieve dental pain.
What is the current status of trial NCT00740857?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 211 participants. The study started on 2008-08. Estimated completion is 2008-11.
What interventions are being tested in trial NCT00740857?
The interventions under investigation include: placebo (DRUG), ibuprofen Formulation 1 (DRUG), ibuprofen Formulation 2 (DRUG).
Who is sponsoring clinical trial NCT00740857?
This trial is sponsored by Wyeth is now a wholly owned subsidiary of Pfizer, which has 167 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00740857's enrollment target sits among peer trials
211 398th of 2000 higher than 1,603 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06698796 · 211 participants · Phase 3
A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies
- NCT04228978 · 212 participants · NA
Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss
- NCT04725721 · 212 participants · NA
Testing FIRST in Youth Outpatient Psychotherapy
- NCT06257576 · 212 participants · Phase 3
Function of Tamsulosin in Older Males Undergoing Surgery with Indwelling Catheter
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia